Ribomic Inc. announced that Dr. Quan Dong Nguyen, Professor of Ophthalmology at the Byers Eye Institute at Stanford University, and Dr. Karl G. Csaky, the T. Boone Pickens Director of the Clinical Center of Innovation for Age-Related Macular Degeneration and the Managing Director and Chief Medical Officer at the Retina Foundation of the Southwest have joined the scientific advisory board for RIBOMIC Inc. Dr. Nguyen and Dr. Csaky are highly recognized ophthalmologists and clinician scientists specializing in retina and vitreous disorders. As scientific consultants, they will provide RIBOMIC with professional expertise for the design, coordination, and evaluation of clinical trials that RIBOMIC plans to start in 2018 for patients with AMD in the United States, evaluating the in-house developed anti-FGF2 aptamer (RBM-007).